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Abstract 
In the setting of the current novel coronavirus pandemic, this document has been generated to 
provide guiding statements for the adult cardiac surgeon to consider in a rapidly evolving 
national landscape. Acknowledging the risk for a potentially prolonged need for cardiac surgery 
procedure deferral, the authors have created this proposed template for physicians and 
interdisciplinary teams to consider in protecting their patients, institution and their highly 
specialized cardiac surgery team. In addition, recommendations on the transition from 
traditional in-person patient assessments and outpatient follow-up are provided. Lastly, we 
advocate that the cardiac surgeon must continue to serve as leaders, experts, and relevant 
members of our medical community, shifting our role as necessary in this time of need. 
 
Word Count: 117 
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List of Abbreviations: 
AVR - Aortic Valve Replacement 
CAD – Coronary Artery Disease 
COVID-19 – Novel coronavirus SARS CoV-2 
EF – Ejection Fraction 
LM – Left Main Coronary Artery Disease 
PPE – Personal Protective Equipment 
TAVR - Transcatheter aortic valve replacement 
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Novel coronavirus (SARS CoV-2 or COVID-19) has been declared a worldwide pandemic by the 
World Health Organization. At the time of writing this document, there are over 1,200,000 
reported cases worldwide and over 320,000 in the United States alone.
1
 There is substantial 
regional variation within the United States, particularly extreme in the populous northeast.
2
 
Dependence on hospital infrastructure to manage the outbreak is variable and difficult to 
predict. Mandatory quarantines are present in many states and the Center for Disease Control 
has stated that certain individuals are at higher risk in the setting of the pandemic and should 
avoid close contact with others. This specifically includes patients over 65 years of age and 
those with lung or heart conditions, diabetes, and obesity. This obviously represents the 
majority of the population that requires cardiac surgery. 
 
The intent of this document is to provide guidance to the adult cardiac surgery perioperative 
community regarding management of patients considered or scheduled for surgical procedures 
in the context of the current pandemic. Specifically, contained within is a proposed template 
for physicians and interdisciplinary teams to consider and adapt to the unique aspects of each 
patient in the specific context of the prevalence of COVID-19 at the medical center where they 
are being treated. The purpose of postponing or cancelling cardiac operations is based upon 
these principles: 
 
1) Protecting the cardiac patient: As our hospitals become increasingly populated with 
either suspected or confirmed COVID-19 patients, exposing the cardiac patient to the 
hospital environment will potentially increase their risk of nosocomial infection. It is 
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uncertain how acquisition of COVID-19 in the perioperative phase will impact morbidity 
and mortality.  
 
2) Protecting the institution and society at large: Reducing the number of cardiac surgical 
procedures will result in the preservation of valuable resources that will allow for 
intensive care unit beds, mechanical ventilators, circuitry for extracorporeal membrane 
oxygenation (ECMO), pharmaceuticals, personal protective equipment (PPE) and 
healthcare workers with advanced skills to be used for the ever growing numbers of 
COVID-19 admissions. 
 
3) Protecting the healthcare team: Cardiac surgery requires a relatively small dedicated 
team of uniquely skilled individuals (cardiac operating room scrub and circulators, 
perfusionists, cardiac anesthesiologists, and perioperative caregivers). Utilizing these 
individuals for potentially non-essential operations may increase their chances of 
COVID-19 exposure, threatening their availability for future more urgent procedures. 
There is obviously a balance of risk, as patients with significant cardiovascular disease have 
their definitive treatment delayed versus increasing the likelihood of acquiring a nosocomial 
COVID-19 infection and its consequences.  The factors resulting in delaying a cardiac surgery 
procedure are multifold. Blood products are in short supply as volunteer donation rates are 
substantially reduced under the advisory of avoiding close contact.  Each cardiac surgical 
procedure will necessarily consume increasingly scarce resources (in-patient space, human 
resources, PPE, etc.) that might delay or prevent treatment of a patient suffering from the 
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sequela of a COVID-19 infection. Lastly, there is an increasing awareness of the importance of 
preventing infections of the healthcare team by patients who may be asymptomatic carriers. 
Screening of asymptomatic patients should be determined based upon instutional practice. 
 
At a time when our nation’s healthcare resources are insufficient to meet this unprecedented 
demand, it is necessary to prioritize needs in the hopes of maximizing lives saved. Although 
delaying definitive treatment of cardiovascular disorders may present risk to certain individuals, 
countless others will be afforded life saving resources necessary to overcome the most 
threatening manifestation of this illness (see Tables 1-4). As the duration of COVID-19 burden in 
our hospitals is presently unknown, it is foreseeable that reduction in cardiac surgery capacity 
may be impacted for several months or longer.  For patients whose cardiac surgical procedures 
are being delayed and in whom alternative therapies are not deemed appropriate, programs 
are encouraged to develop an orchestrated follow-up mechanism for regular communication 
(i.e. 1-2 week intervals) to monitor for progession of symptoms by tele or video conference. 
Timely reprioritization can be considered given the dynamic nature of some patients with 
cardiovascular disease.  Each individual case should be given careful consideration, weighing 
risks and potential therapeutic alternatives, including medical treatment, catheter based 
therapy, or even a recommendation to transfer to a center with lower COVID-19 penetrance 
and more available resources. Under these circumstances, it is important to recognize that 
regional competitors must now become collaborators.  
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Programs are encouraged to limit in-person clinic evaluations and testing for appropriately 
selected patients who can be safely deferred, understanding the uncertainty of the pandemic 
duration.  Tele and video visits should be incorporated for both new patient evaluations and 
postoperative assessments. As the morphology of the typical cardiac surgery practice evolves, 
programatic leaders must determine how to effective and safely “skeletonize” hospital and 
office staffing including surgeons, advance practice providers, administrative and clerical 
personnel, and in some cases creating opporutnites for team members to work from home. 
There should also be specific consideration to accommodate individuals at higher risk of COVID-
19 because of advanced age or the presence of underlying health conditions.  
 
As our surgical volume declines over the next several months, it is essential that the 
cardiothoracic surgical community maintains its commitment to the health and safety of its 
patients. While hospitals shift their focus to medical management of this outbreak, cardiac 
surgeons may feel uncertainty about their role. In addition to our expertise in the care of 
advanced cardiac disease, there will also likely be an expanded need for the use of ECMO, 
requiring cardiac surgical direction and partnership with the Extracorporeal Life Support 
Organization
3
.  We must continue to serve as leaders, experts, and members of our medical 
community, willing to play any role necessary in this time of need.  
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Table 1: Guiding statement for patient triage during Tier 1 (0-30% inpatient COVID-19 Load, 
mild reduction in operative capacity) 
 
TIER 1 
Essential services Deferred 
• All in-patients waiting for surgery including 
emergency services (i.e. ascending aortic 
dissections, acute coronary syndromes, acute 
valvular endocarditis, and heart failure patients 
awaiting heart transplant or VAD) 
• Outpatients who are at greatest risk of adverse 
event, examples of which include: 
o Symptomatic critical AS 
o CAD 
 Severe CAD with large territory of 
myocardium at risk.  
 Asymptomatic CAD with reduced 
systolic function. 
 Progressive angina 
o Cardiac tumors at risk of obstruction or 
embolization 
o Aortic aneurysm at risk based on size and 
familial association  
o Patients with correctable, anatomic 
causes of heart failure (valvular or 
• Asymptomatic Outpatients 
• Truly elective intervention could 
include  
o Asymptomatic or 
minimally symptomatic 
severe MR 
o ASD and or PFO surgery  
o Asymptomatic aneurysm 
with demonstrated stable 
size 
o Isolated arrhythmia 
procedures 
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myocardial, ie. HCM, adult congenital) 
o End-stage heart failure patients in 
evaluation for mechanical assist devices 
whom are inotrope dependent 
 Programs are encouraged to adopt a mechanism by which patients can be screened regularly 
in order to identify those having increased symptoms or progression of disease 
 Transcatheter interventions will follow the same recommendations  
 Alternative percutaneous therapies with rapid discharge from the hospital should be 
considered 
 Thoracic Organ Transplant guidance is provided by the United Network for Organ Sharing 
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Table 2:   Guiding statement for patient triage during Tier 2 (30-60% inpatient COVID-19 Load, 




Essential services Deferred 
• All in-patients waiting for surgery 
including emergency services 
• Outpatients with progressive 
symptomatology who have 
demonstrated  failure to  medical 
management 
o   Symptomatic CAD 
• Asymptomatic CAD with impaired 
systolic function 
• Asymptomatic outpatients and patients 
with anatomy and physiology suggesting 
delay can be provided with reasonable 
safety. 
  
 Programs are encouraged to adopt a mechanism by which patients can be screened 
regularly in order to identify those having increased symptoms or progression of disease 
 Transcatheter interventions will follow the same recommendations  
 Alternative percutaneous therapies with rapid discharge from the hospital should be 
considered 
 Thoracic Organ Transplant guidance is provided by the United Network for Organ Sharing  
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Table 3:   Guiding statement for patient triage during Tier 3 (60-80% inpatient COVID-19 Load, 
severe reduction in operative capacity) 
 
TIER 3 
Essential services Deferred 
• All in-patients who cannot be discharged 
safely without surgical intervention/ 
correction including emergency services 
  
• All patients who are outpatients 
• Patients deteriorating while waiting 
would need to meet criteria for 
admission before consideration for 
surgery 
  
 Programs are encouraged to adopt a mechanism by which patients can be screened 
regularly in order to identify those having increased symptoms or progression of disease  
 Transcatheter interventions will follow the same recommendations  
 Alternative percutaneous therapies with rapid discharge from the hospital should be 
considered  
 Thoracic Organ Transplant guidance is provided by the United Network for Organ Sharing  
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Table 4:   Guiding statement for patient triage during Stage 4 (>80% inpatient COVID Load, 
minimal operative capacity) 
 
TIER 4 
Essential services Deferred 
• Only emergency services based on 
resource availability  
 
• All inpatients judged to be stable and 
capable of waiting 
• All outpatients 
  
 With extreme reductions in operative capacity, ability (or inability) to perform surgery should 
be evaluated in the case of emergent cases, alternate arrangements at peer institutions with 
potential capacity should be sought 
 Thoracic Organ Transplant guidance is provided by the United Network for Organ Sharing 
 
